UPDATE: Teva Pharma (TEVA) Tops Q4 EPS by 1c, Offers FY20 Guidance

Go back to UPDATE: Teva Pharma (TEVA) Tops Q4 EPS by 1c, Offers FY20 Guidance

Teva Pharma (TEVA) Gains 7.5% Following Results

February 12, 2020 9:33 AM EST

Teva Pharma (NYSE: TEVA) gains 7.5% off the open following results.

... More